Xeris Biopharma Holdings Inc (XERS)
Free Cash Flow Growth
8403.09%
Quarterly · Period ending:
XERS Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported8403.09%period ending
Latest reported8403.09%period ending
XERS Quarterly Free Cash Flow YoY % (-110.77% → 8403.09%)
Year-over-year change
High-resolution chart · PNG
XERS free cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Free Cash Flow Growth |
|---|---|
| 8,403.0928% | |
| 195.0319% | |
| 1,023.0769% | |
| 315.3122% | |
| 99.0973% | |
| 50.9259% | |
| -71.482% | |
| 43.885% | |
| 29.7345% | |
| 22.4088% | |
| 137.8684% | |
| 16.5923% | |
| 26.569% | |
| 45.5101% | |
| 44.1105% | |
| 21.7646% | |
| -2.8903% | |
| -98.5196% | |
| -162.0966% | |
| -35.0899% | |
| 15.3315% | |
| 15.8296% | |
| 62.7918% | |
| 45.1893% | |
| -2.4602% | |
| -35.6701% | |
| -60.4305% | |
| -85.4746% | |
| -62.2687% | |
| -162.3986% | |
| -99.0681% | |
| -197.8936% | |
| -119.0433% | |
| -110.7744% |